“Real-World Effectiveness of Up to 12-Month Tralokinumab Treatment in Adults With Atopic Dermatitis Who Previously Discontinued Dupilumab or Janus Kinase Inhibitors” (2026) SKIN The Journal of Cutaneous Medicine, 10(2), p. s728. doi:10.25251/wx06pe13.